Annual accounts receivable:
$30.06M+$5.00M(+19.94%)Summary
- As of today (July 1, 2025), LMAT annual accounts receivable is $30.06 million, with the most recent change of +$5.00 million (+19.94%) on December 31, 2024.
- During the last 3 years, LMAT annual accounts receivable has risen by +$10.43 million (+53.14%).
- LMAT annual accounts receivable is now at all-time high.
Performance
LMAT Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$35.11M+$5.05M(+16.79%)Summary
- As of today (July 1, 2025), LMAT quarterly accounts receivable is $35.11 million, with the most recent change of +$5.05 million (+16.79%) on March 31, 2025.
- Over the past year, LMAT quarterly accounts receivable has increased by +$4.88 million (+16.13%).
- LMAT quarterly accounts receivable is now at all-time high.
Performance
LMAT Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
LMAT Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.9% | +16.1% |
| 3 y3 years | +53.1% | +64.2% |
| 5 y5 years | +81.4% | +111.1% |
LMAT Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.1% | at high | +74.7% |
| 5 y | 5-year | at high | +81.4% | at high | +98.4% |
| alltime | all time | at high | +757.7% | at high | +901.8% |
LMAT Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $35.11M(+16.8%) |
| Dec 2024 | $30.06M(+19.9%) | $30.06M(-6.8%) |
| Sep 2024 | - | $32.27M(+4.7%) |
| Jun 2024 | - | $30.82M(+1.9%) |
| Mar 2024 | - | $30.24M(+20.6%) |
| Dec 2023 | $25.06M(+13.7%) | $25.06M(+4.9%) |
| Sep 2023 | - | $23.88M(-9.6%) |
| Jun 2023 | - | $26.41M(+4.1%) |
| Mar 2023 | - | $25.36M(+15.1%) |
| Dec 2022 | $22.04M(+12.3%) | $22.04M(+9.7%) |
| Sep 2022 | - | $20.09M(-6.7%) |
| Jun 2022 | - | $21.54M(+0.7%) |
| Mar 2022 | - | $21.39M(+8.9%) |
| Dec 2021 | $19.63M(+0.4%) | $19.63M(+0.7%) |
| Sep 2021 | - | $19.50M(-6.0%) |
| Jun 2021 | - | $20.74M(+3.1%) |
| Mar 2021 | - | $20.13M(+2.9%) |
| Dec 2020 | $19.55M(+18.0%) | $19.55M(-0.4%) |
| Sep 2020 | - | $19.63M(+10.9%) |
| Jun 2020 | - | $17.70M(+6.4%) |
| Mar 2020 | - | $16.63M(+0.3%) |
| Dec 2019 | $16.57M(+5.4%) | $16.57M(+11.4%) |
| Sep 2019 | - | $14.88M(-4.3%) |
| Jun 2019 | - | $15.55M(+0.6%) |
| Mar 2019 | - | $15.46M(-1.7%) |
| Dec 2018 | $15.72M(+4.8%) | $15.72M(+20.8%) |
| Sep 2018 | - | $13.02M(-14.5%) |
| Jun 2018 | - | $15.23M(+5.0%) |
| Mar 2018 | - | $14.51M(-3.3%) |
| Dec 2017 | $15.00M(+13.7%) | $15.00M(+10.7%) |
| Sep 2017 | - | $13.55M(-7.1%) |
| Jun 2017 | - | $14.59M(+3.5%) |
| Mar 2017 | - | $14.09M(+6.8%) |
| Dec 2016 | $13.19M(+10.2%) | $13.19M(+8.3%) |
| Sep 2016 | - | $12.18M(-5.2%) |
| Jun 2016 | - | $12.84M(-1.4%) |
| Mar 2016 | - | $13.02M(+8.7%) |
| Dec 2015 | $11.97M | $11.97M(+5.6%) |
| Sep 2015 | - | $11.34M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $12.24M(+3.1%) |
| Mar 2015 | - | $11.88M(+9.9%) |
| Dec 2014 | $10.80M(+2.0%) | $10.80M(+2.0%) |
| Sep 2014 | - | $10.59M(-6.9%) |
| Jun 2014 | - | $11.37M(+8.4%) |
| Mar 2014 | - | $10.49M(-0.9%) |
| Dec 2013 | $10.59M(+17.0%) | $10.59M(+14.2%) |
| Sep 2013 | - | $9.27M(-4.5%) |
| Jun 2013 | - | $9.71M(+3.8%) |
| Mar 2013 | - | $9.36M(+3.4%) |
| Dec 2012 | $9.05M(+5.9%) | $9.05M(+6.8%) |
| Sep 2012 | - | $8.47M(-3.7%) |
| Jun 2012 | - | $8.80M(+1.3%) |
| Mar 2012 | - | $8.69M(+1.7%) |
| Dec 2011 | $8.54M(+0.8%) | $8.54M(-3.5%) |
| Sep 2011 | - | $8.85M(-2.3%) |
| Jun 2011 | - | $9.07M(-3.3%) |
| Mar 2011 | - | $9.37M(+10.6%) |
| Dec 2010 | $8.47M(+9.0%) | $8.47M(+3.8%) |
| Sep 2010 | - | $8.17M(+3.9%) |
| Jun 2010 | - | $7.86M(-2.4%) |
| Mar 2010 | - | $8.05M(+3.5%) |
| Dec 2009 | $7.78M(+7.4%) | $7.78M(-0.8%) |
| Sep 2009 | - | $7.84M(+0.9%) |
| Jun 2009 | - | $7.77M(+8.4%) |
| Mar 2009 | - | $7.16M(-1.1%) |
| Dec 2008 | $7.24M(+3.2%) | $7.24M(+6.7%) |
| Sep 2008 | - | $6.79M(-5.0%) |
| Jun 2008 | - | $7.15M(-0.3%) |
| Mar 2008 | - | $7.17M(+2.1%) |
| Dec 2007 | $7.02M(+38.7%) | $7.02M(+12.8%) |
| Sep 2007 | - | $6.22M(+2.3%) |
| Jun 2007 | - | $6.08M(+6.9%) |
| Mar 2007 | - | $5.69M(+12.4%) |
| Dec 2006 | $5.06M(+20.3%) | $5.06M(+5.2%) |
| Sep 2006 | - | $4.81M(-2.4%) |
| Jun 2006 | - | $4.92M(+2.1%) |
| Mar 2006 | - | $4.83M(+14.7%) |
| Dec 2005 | $4.21M(+20.0%) | $4.21M(+20.0%) |
| Dec 2004 | $3.50M | $3.50M |
FAQ
- What is LeMaitre Vascular annual accounts receivable?
- What is the all time high annual accounts receivable for LeMaitre Vascular?
- What is LeMaitre Vascular annual accounts receivable year-on-year change?
- What is LeMaitre Vascular quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for LeMaitre Vascular?
- What is LeMaitre Vascular quarterly accounts receivable year-on-year change?
What is LeMaitre Vascular annual accounts receivable?
The current annual accounts receivable of LMAT is $30.06M
What is the all time high annual accounts receivable for LeMaitre Vascular?
LeMaitre Vascular all-time high annual accounts receivable is $30.06M
What is LeMaitre Vascular annual accounts receivable year-on-year change?
Over the past year, LMAT annual accounts receivable has changed by +$5.00M (+19.94%)
What is LeMaitre Vascular quarterly accounts receivable?
The current quarterly accounts receivable of LMAT is $35.11M
What is the all time high quarterly accounts receivable for LeMaitre Vascular?
LeMaitre Vascular all-time high quarterly accounts receivable is $35.11M
What is LeMaitre Vascular quarterly accounts receivable year-on-year change?
Over the past year, LMAT quarterly accounts receivable has changed by +$4.88M (+16.13%)